Current Understanding of Androgenetic Alopecia: Part I - Etiopathogenesis

    June 2000 in “ PubMed ”
    Rolf Hoffmann, Rudolf Happle
    Studysummary This article reviews the molecular mechanisms involved in androgenetic alopecia, focusing on the role of type 2 5α-reductase and DHT, but presents no new findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 9

    1. Pharmacological Therapeutics in Androgenetic Alopecia Journal of The Korean Medical Association · 2020
    2. Minoxidil to Treat Androgenetic Alopecia in Men and Women: What Is It and How Does It Work? American Journal of Medicine and Medical Sciences · 2014
    3. Finasteride as a Treatment for Male Androgenetic Alopecia e-Jurnal Medika Udayana · 2013
    4. 5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia International Journal of Cosmetic Surgery and Aesthetic Dermatology · 2001
    5. The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1999
    6. Clinical Updates in Hair Dermatologic Clinics · 1997
    7. The Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients with Male Pattern Baldness The Journal of Clinical Endocrinology and Metabolism · 1994
    8. Biochemical Mechanisms Regulating Human Hair Growth Skin Pharmacology and Physiology · 1994
    9. Drugs Affecting Hair Growth 1990